Human assembloids reveal the consequences of gene variants in the thalamocortical pathway

Ji-il Kim,Yuki Miura,Min-Yin Li,Omer Revah,Sridhar Selvaraj,Fikri Birey,Xiangling Meng,Mayuri Vijay Thete,Sergey D. Pavlov,Jimena Andersen,Anca M. Pașca,Matthew H. Porteus,John R. Huguenard,Sergiu P. Pașca
DOI: https://doi.org/10.1101/2023.03.15.530726
2024-09-09
Abstract:Abnormalities in crosstalk between the thalamus and the cerebral cortex are thought to lead to severe neuropsychiatric disorders, such as epilepsy and psychotic disorders. Pathogenic variants in the CACNA1G gene, which encodes the α1G subunit of the thalamus-enriched T-type voltage-gated calcium channel CaV3.1, are associated with absence seizures, intellectual disability, and schizophrenia, but the cellular and circuit level consequences of these genetic variants in humans remain unknown. Here, we developed an in vitro human assembloid model of the thalamocortical pathway to systematically dissect the contribution of genetic variants in T-type calcium channels. We discovered that a CACNA1G variant (M1531V) associated with seizures led to changes in T-type currents in human thalamic neurons, as well as correlated hyperactivity of thalamic and cortical neurons in thalamo-cortical assembloids. In contrast, CACNA1G loss, which has been associated with risk of schizophrenia, resulted in abnormal thalamocortical connectivity that was related to both increased spontaneous thalamic activity and aberrant thalamic axonal projections. Taken together, these results illustrate the utility of organoid and assembloid systems for interrogating human genetic disease risk variants at both cellular and circuit level.
Neuroscience
What problem does this paper attempt to address?